Clinical Scorecard: In the World of Anti-Myopia Spectacles, Where Does Ortho-k Fit into My Practice?
At a Glance
| Category | Detail |
|---|---|
| Condition | Myopia |
| Key Mechanisms | Inducing myopic defocus or reducing retinal contrast to slow eye growth. |
| Target Population | Younger children, pre-myopes, and families uncertain about contact lens wear. |
| Care Setting | Clinical practice focusing on myopia management. |
Key Highlights
- FDA approval of anti-myopia spectacles (EssilorStellest) marks a milestone for myopia control.
- Spectacles are the most accessible and least invasive myopia-control intervention.
- Ortho-k offers unique advantages, including customized myopic defocus and no daytime device.
- Patient education and compliance are critical for the efficacy of myopia control interventions.
- Comprehensive approach to intervention selection is essential, considering individual patient context.
Guideline-Based Recommendations
Diagnosis
- Assess refractive error, patient age, axial elongation, and corneal shape.
Management
- Consider ortho-k for moderate myopes (-1.00 to -5.00 D) with astigmatism up to -1.50 D.
Monitoring & Follow-up
- Ensure consistent follow-up and monitor corneal health for ortho-k patients.
Risks
- Compliance with wear time is a key limitation for spectacle efficacy.
Patient & Prescribing Data
Children and adolescents with myopia.
Use full-strength single vision lenses as backup and low-minus options for mild regression.
Clinical Best Practices
- Educate patients on the importance of consistent wear for efficacy.
- Tailor intervention selection based on individual lifestyle and visual goals.
- Utilize a multi-tool approach for myopia management.
References
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.